Cancer vaccines using supramolecular hydrogels of NSAID-modified peptides as adjuvants abolish tumorigenesis-Reference-Cited by-同舟云学术

Cancer vaccines using supramolecular hydrogels of NSAID-modified peptides as adjuvants abolish tumorigenesis

Author:

Wang Zhongyan¹²³⁴⁵,Liang Chunhui⁶⁷⁸⁹¹⁰,Shi Fang¹²³⁴⁵,He Tao¹¹¹²¹³¹⁴¹⁵,Gong Changyang¹¹¹²¹³¹⁴¹⁵,Wang Ling⁶⁷⁸⁹¹⁰,Yang Zhimou¹²³⁴⁵^ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology

2. Key Laboratory of Bioactive Materials

3. Ministry of Education

4. College of Life Sciences

5. and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin)

6. State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy

7. Tianjin Key Laboratory of Molecular Drug Research

8. Nankai University

9. Tianjin 300071

10. P. R. China

11. State Key Laboratory of Biotherapy and Cancer Center

12. West China Hospital

13. Sichuan University

14. and Collaborative Innovation Center for Biotherapy

15. Chengdu 610041

Abstract

We demonstrated in this study that supramolecular hydrogels of NSAID-modified peptides are promising adjuvants for cancer vaccine development.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

Reference46 articles.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory hydrogels;Multiscale Cell-Biomaterials Interplay in Musculoskeletal Tissue Engineering and Regenerative Medicine;2024